US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, LOGONE BIO CONVERGENCE RESEARCH FOUNDATION on Sept. 23 for "Type 1 interferon neutralizing FC-fusion protein and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,297, issued on Sept. 23, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea) and LOGONE BIO CONVERGENCE RESEARCH FOUNDATION (Seoul, South Korea).

"Type 1 interferon neutralizing FC-fusion protein and use thereof" was invented by Young Kee Shin (Seoul, South Korea), Sae Hyung Lee (Seoul, South Korea) and Sung Su Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a type 1 interferon neutralizing FC-fusion protein and a use thereof and, more specifically, to: a dimer-type polypeptide to which a monomer comprising an interferon receptor fragment or an antibody Fc fragment i...